Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Roche (ROG.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (CHF) Price Target (CHF) Rating
2022-02-18342.55345.00Neutral
2022-04-19377.25345.00Sell
2022-07-11326.45328.00Neutral
2022-09-05319.20-No Rating
2022-09-28325.45328.00Neutral
2022-12-14307.55329.00Neutral
2023-01-09291.40315.00Neutral
2023-03-02273.90290.00Neutral
2023-05-12284.75280.00Neutral
2024-01-15250.85262.00Neutral
2024-02-05230.50248.00Neutral
2024-04-25218.80238.00Neutral
2024-09-16264.10270.00Neutral
2025-01-31286.00300.00Neutral
2025-02-13297.80338.00Buy
2025-04-25261.90314.00Buy

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.